The American Journal of Managed Care6h
Revolutionizing NSCLC Care With Circulating Tumor DNA and MRD Assays
Divya Gupta, MD, assistant professor at Feinberg School of Medicine at Northwestern University, discussed the potential of using circulating tumor DNA and minimal residual disease (MRD) assays for ...
Medscape6d
Update on Antiretroviral Drug Resistance Testing: Combining Laboratory Technology With Patient Care
The 3 most prevalent mutation detection methodologies are DNA sequencing, gene chip arrays, and the line probe assay. The gene chip and line probe assays are commonly grouped together as "probe ...
Hoodline13d
Harvard Scientists Pioneer HACE, a New Technique for Targeted Gene Mutation in Human Cells
Harvard researchers pioneered a method called HACE for targeted gene mutations, advancing genetic research potential.
The American Journal of Managed Care7d
Targeted Therapies, Genomic Profiling Revolutionize Breast Cancer Treatment
Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah, discusses the latest advancements in HR+/HER2– breast cancer research, as well as the ...
Medscape13d
Molecular Methods in the Diagnosis and Management of Chronic Hepatitis B
oligonucleotide chips and line-probe assays have much higher relative sensitivity compared with sequencing. Assays with higher sensitivity will detect resistance mutations at an earlier point in ...